Safety and Efficacy of Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Advanced Breast Cancer: A Head-to-Head Comparison of Margetuximab versus Trastuzumab

被引：2
|
作者：
Zhang, Liyi [1 ]
机构：
[1] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Peoples R China
来源：
ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING | 2021年 / 8卷 / 04期
关键词：
FC-GAMMA RECEPTORS; MONOCLONAL-ANTIBODY; CHEMOTHERAPY; MGAH22;
D O I：
10.4103/apjon.apjon-2128
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
引用
收藏
页码：349 / 351
页数：3
相关论文
共 50 条
  • [1] Human epidermal growth factor receptor 2-targeted therapies in breast cancer
    Nahta, Rita
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (07) : 949 - 952
  • [2] Resistance to human epidermal growth factor receptor type 2-targeted therapies
    Thery, Jean-Christophe
    Spano, Jean-Philippe
    Azria, David
    Raymond, Eric
    Llorca, Frederique Penault
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 (05) : 892 - 901
  • [3] Cardiotoxicity of Epidermal Growth Factor Receptor 2-Targeted Drugs for Breast Cancer
    Yang, ZiYan
    Wang, Wei
    Wang, Xiaojia
    Qin, ZhiQuan
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [4] Estrogen Receptor and Receptor Tyrosine Kinase Signaling: Use of Combinatorial Hormone and Epidermal Growth Factor Receptor/Human Epidermal Growth Factor Receptor 2-Targeted Therapies for Breast Cancer
    Zabransky, Daniel J.
    Park, Ben Ho
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (10) : 1084 - 1086
  • [5] Safety and Efficacy of Trastuzumab Emtansine in Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: a Meta-analysis
    Kai Shen
    Xuelei Ma
    Chenjing Zhu
    Xin Wu
    Hongyuan Jia
    [J]. Scientific Reports, 6
  • [6] Efficacy and tolerability of trastuzumab emtansine in advanced human epidermal growth factor receptor 2-positive breast cancer
    Yeo, Winnie
    Luk, M. Y.
    Soong, Inda S.
    Yuen, Tony Y. S.
    Ng, T. Y.
    Mo, Frankie K. F.
    Chan, K.
    Wong, S. Y.
    Tsang, Janice
    Leung, Carmen
    Suen, Joyce J. S.
    Ngan, Roger K. C.
    [J]. HONG KONG MEDICAL JOURNAL, 2018, 24 (01) : 56 - 62
  • [7] Safety and Efficacy of Trastuzumab Emtansine in Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: a Meta-analysis
    Shen, Kai
    Ma, Xuelei
    Zhu, Chenjing
    Wu, Xin
    Jia, Hongyuan
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [8] PIK3CA Mutations Are Associated With Decreased Benefit to Neoadjuvant Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Breast Cancer
    Majewski, Ian J.
    Nuciforo, Paolo
    Mittempergher, Lorenza
    Bosma, Astrid J.
    Eidtmann, Holger
    Holmes, Eileen
    Sotiriou, Christos
    Fumagalli, Debora
    Jimenez, Jose
    Aura, Claudia
    Prudkin, Ludmila
    Carmen Diaz-Delgado, Maria
    de la Pena, Lorena
    Loi, Sherene
    Ellis, Catherine
    Schultz, Nikolaus
    de Azambuja, Evandro
    Harbeck, Nadia
    Piccart-Gebhart, Martine
    Bernards, Rene
    Baselga, Jose
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (12) : 1334 - 1339
  • [9] Trastuzumab emtansine in advanced human epidermal growth factor receptor 2-positive breast cancer
    Van den Mooter, Tom
    Teuwen, Laure-Anne
    Rutten, Annemie
    Dirix, Luc
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (05) : 749 - 760
  • [10] Epidermal Growth Factor Receptor-Targeted Therapy for Head and Neck Cancer
    Trivedi, Sumita
    Ferris, Robert L.
    [J]. OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2021, 54 (04) : 743 - 749
12345